In the United States, approximately 1.5 million new cancer cases were expected to be diagnosed in 2010, excluding most carcinomas
in situ (noninvasive cancers) as well as basal and squamous cell skin cancers.
1 Over half a million Americans were expected to die of cancer, more than 1,500 people a day in the year 2010.
1 Cancer is the second most common cause of death in the US, exceeded only by heart disease.
1 The 5-year relative survival rate for all cancers diagnosed between 1999 and 2005 was 68%, up from 50% in 1975 to 1977. The improvement in survival reflects progress in diagnosing certain cancers earlier and improvements in treatment. More than 85% of cancers originate in the epithelium, and epithelial cancers are preceded by a curable pre-cancerous stage, when 95% of cases completely recover.
2 Cancer detection is further complicated by field cancerization or multicentric lesions. Current diagnostic techniques require repeated surgical biopsies of lesions that frequently turn out to be benign, yet they often also detect malignant change too late for curative treatment. Of all oral cancer cases documented by the National Cancer Institute, advanced lesions outnumbered localized lesions at the time of diagnosis by more than 2:1. These statistics mean that at least some lesions were ignored or missed by patients, healthcare professionals, or both. It is partly due to an incomplete understanding or awareness that even small asymptomatic lesions can have significant malignant potential and partly due to the lack of effective diagnostic modalities. Five-year survival rate is only 16% for patients with oral cancer metastasis, but 75% for those with localized disease at the time of diagnosis.
1, 2 The current approach to detecting malignant change in existing oral lesions that are potentially pre-dysplastic or dysplastic is regular surveillance combined with biopsy or surgical excision. However, these techniques are invasive, often poorly tolerated by patients, may miss additional lesions or areas of more severe pathology, and unsuitable for regular screening of high risk sectors of the population.